pan-tropomyosin receptor kinase (Trk) inhibitor (Ono Pharmaceutical)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namepan-tropomyosin receptor kinase (Trk) inhibitor (Ono Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTropomyosin inhibitors
TargetsTropomyosin
Therapy Area/IndicationsOsteoarthritisBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOno Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsOsteoarthritisBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A